> The company, which is incorporated in the United States but generates most of its revenue in South Korea, said it would challenge the ruling in court. The regulatory probe has grown into a rare diplomatic dispute between Washington and Seoul. Coupang and some Republican members of Congress have accused the South Korean government of weaponizing regulatory proceedings against an American company.

https://www.nytimes.com/2026/06/11/world/asia/south-korea-co...